This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Determining the best age to start retirement planning can set you on a path to financial success. Learn why starting early matters.
18,401 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A new venue now enables 24/7 crypto trading, including weekends. Early weekend data shows growing interest and liquid...
As money flows into SPY accelerate, four small-cap ETFs are quietly delivering outsized gains. This report breaks dow...
New York Fed researchers find a widening gap in how households respond to rising gas prices after the Iran-related sh...
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...
Investors eyeing mdxhealth (mdxh) 2026 earnings will focus on adoption rates, reimbursement, and partnerships. This g...
Investors woke up to news that rocket stock dropped today, sending shares of Rocket Lab into the spotlight. This arti...
A high-flying semiconductor stock grabbed headlines as it soared. Yet one large investor chose to sell an $89 million...
Looking ahead two decades can feel daunting, but some stocks stand out as reliable winners. This guide reveals three ...
Tesla’s 2026 year foundational growth centers on ramping four key initiatives that lay the groundwork for the next wa...
In May, Figma delivered a performance surge that surprised many investors. This article breaks down the key drivers b...
A major AI and cloud deal is flanking SpaceX's IPO, potentially nudging investor sentiment. This article breaks down ...